Digital Therapeutics Market Analysis, Size, and Forecast 2024-2028: North America (US and Canada), Europe (France, Germany, Italy, and UK), Middle East and Africa (Egypt, KSA, Oman, and UAE), APAC (China, India, and Japan), South America (Argentina and Brazil), and Rest of World (ROW)

Digital Therapeutics Market Size 2024-2028

The digital therapeutics market size is valued to increase USD 19.17 billion, at a CAGR of 32.59% from 2023 to 2028. Increasing prevalence of chronic diseases will drive the digital therapeutics market.

Major Market Trends & Insights

• North America dominated the market and accounted for a 39% growth during the forecast period.
• By Product - Software segment was valued at USD 1.83 billion in 2022
• By End-user - Business-to-Consumer segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 956.60 million
• Market Future Opportunities: USD 19174.90 million
• CAGR : 32.59%
• North America: Largest market in 2022

Market Summary

• The market represents a burgeoning sector at the intersection of healthcare and technology, characterized by the use of digital interventions to prevent, manage, or treat medical conditions. Core technologies, including artificial intelligence, machine learning, and mobile applications, are driving innovation in this space, enabling the development of personalized and adaptive interventions. The market's applications span various health conditions, with mental health, cardiology, and diabetes being major focus areas. Service types range from software as a service (SaaS) to fully integrated digital therapeutics solutions.
• Despite the market's promising growth, challenges such as high development and regulatory costs persist. According to a recent report, the market is expected to account for over 20% of the global digital health market by 2026, underscoring its increasing importance. The ongoing prevalence of chronic diseases and the rising adoption of technology-driven healthcare solutions are key market drivers.

What will be the Size of the Digital Therapeutics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Digital Therapeutics Market Segmented and what are the key trends of market segmentation?

The digital therapeutics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Product
  • Software
  • Devices
• End-user
  • Business-to-Consumer
  • Business-to-Business
• Application
  • Preventive Applications
  • Prediabetes
  • Obesity
  • Smoking Cessation
  • Treatment/Care Applications
  • Diabetes
  • Mental Health
  • Cardiovascular Diseases
  • Chronic Respiratory Diseases
  • Substance Abuse
  • Musculoskeletal Disorders
  • Others
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • Middle East and Africa
    • Egypt
    • KSA
    • Oman
    • UAE
  • APAC
    • China
    • India
    • Japan
  • South America
    • Argentina
    • Brazil
  • Rest of World (ROW)

By Product Insights

The software segment is estimated to witness significant growth during the forecast period.

The market is experiencing substantial expansion, driven by the increasing adoption of software solutions as healthcare interventions. Approximately 25% of healthcare organizations have already implemented digital therapeutics, and this number is projected to rise to 40% within the next three years. Software products, including mobile applications, web-based platforms, and virtual coaching tools, are at the forefront of this growth. To enhance user engagement and effectiveness, software developers are focusing on creating user-friendly interfaces, advanced analytics tools, and interoperability features. Partnerships and collaborations between software developers and healthcare organizations are fueling innovation and broadening market reach. Behavioral health programs, such as cognitive behavioral therapy and patient adherence metrics, are gaining traction in the market.

Wearable sensor data and artificial intelligence algorithms are being integrated into these programs to provide personalized interventions and improve therapeutic efficacy. Augmented reality therapy and virtual reality therapy are also emerging as promising digital therapeutic solutions. Telehealth integration, clinical trial outcomes, and prescription digital therapeutics are other key trends shaping the market. Digital therapeutics are increasingly being used for chronic disease management and evidence-based interventions. Data security protocols, health outcome assessments, and remote patient monitoring are critical considerations for software developers to ensure patient privacy and data integrity. The market for digital therapeutics is expected to grow significantly, with an estimated 35% of healthcare providers planning to invest in digital therapeutics within the next five years.

This growth is being driven by the increasing demand for personalized medicine apps, therapeutic efficacy, and digital biomarker detection. Gamified health interventions, patient reported outcomes, and mobile application development are also contributing to the market's expansion. User experience design, patient engagement platforms, data analytics dashboards, and treatment efficacy data are essential components of digital therapeutics. Interoperability standards, clinical validation studies, and therapeutic efficacy are critical factors that software developers must address to ensure the success of their products in the market.

Request Free Sample

The Software segment was valued at USD 1.83 billion in 2018 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 39% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Digital Therapeutics Market Demand is Rising in North America Request Free Sample

In 2023, the market in North America experienced substantial expansion. Government initiatives have been instrumental in facilitating the incorporation of digital therapeutics into healthcare systems. Regulatory bodies like the US Food and Drug Administration (FDA) have established guidelines to ensure the safety and efficacy of these interventions, bolstering confidence among patients and healthcare providers. Consequently, digital therapeutic adoption has surged. Manufacturers in North America have been pioneering innovative solutions, employing advanced technologies such as AI, machine learning (ML), and data analytics, to deliver personalized and efficient interventions.

According to recent reports, over 50% of digital therapeutics companies in North America have integrated AI technology into their offerings. Additionally, the number of digital therapeutic apps downloaded in the region increased by 30% in the last year. These trends underscore the dynamic and evolving nature of the market in North America.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The global digital therapeutics market is evolving as healthcare systems adopt technology-driven solutions to improve patient care and outcomes. Mobile health applications now integrate patient engagement tools with wearable sensor data integration platforms, enabling continuous monitoring and personalized medicine delivery. Artificial intelligence driven health interventions are transforming clinical decision support systems, while software as medical device regulatory compliance ensures that these technologies meet strict safety and efficacy requirements.

Quantitative assessments highlight how clinical validation digital therapeutics are demonstrating measurable results. For example, platforms designed for chronic disease management digital therapeutics show adherence improvements of over 30% compared with conventional treatment methods, while patient reported outcome measurement tools deliver higher accuracy in health outcome assessment digital biomarker analysis than traditional surveys. This comparison underscores the increasing reliability of evidence based digital health intervention approaches.

Market dynamics are strongly influenced by advancements in therapeutic efficacy clinical trial data, which enhance the credibility of remote patient monitoring telehealth integration solutions. Health behavior change gamified intervention strategies and medication adherence support systems are gaining traction as user experience design mobile health apps improve accessibility. Furthermore, interoperability standards digital health ecosystem and data security protocols for digital health remain critical in supporting real world evidence digital therapeutics deployment. Collectively, these elements reflect a market defined by rapid innovation, stronger regulatory frameworks, and growing emphasis on long-term patient outcomes.

What are the key market drivers leading to the rise in the adoption of Digital Therapeutics Industry?

• The rising prevalence of chronic diseases serves as the primary market driver, significantly expanding the market scope. 

• The market is witnessing significant growth due to the increasing burden of chronic diseases worldwide. Chronic conditions, such as diabetes, cardiovascular diseases, and mental health issues, are the leading causes of mortality and morbidity globally, according to the World Health Organization. In the US alone, 40% of the population has two or more chronic diseases, and 60% have three or more in 2022, as reported by the Centers for Disease Control and Prevention. Digital therapeutics offer a promising solution to improve patient outcomes and reduce healthcare costs.
• This approach leverages digital technologies, such as mobile apps, wearable devices, and software applications, to prevent, manage, and treat various medical conditions. The market's continuous evolution reflects the ongoing efforts to develop innovative solutions that cater to the growing demand for effective and affordable treatment alternatives in the face of the increasing prevalence of chronic diseases.

What are the market trends shaping the Digital Therapeutics Industry?

• The rising adoption of personalized and adaptive interventions is an emerging market trend. This trend signifies a shift towards customized solutions that cater to individual needs and preferences.

• In the dynamic global the market, personalized and adaptable interventions are gaining significant attention. These innovative solutions cater to patients' unique needs, interests, and lifestyles through data analytics, artificial intelligence, and machine learning. For example, WellDoc offers personalized mental health interventions, such as cognitive-behavioral therapy, mindfulness techniques, and positive psychology exercises, for patients with substance use disorders. Similarly, Pear Therapeutics provides cognitive-behavioral therapy to patients dealing with substance use disorders. These tailored interventions enable patients to access more engaging and effective treatment options, ultimately enhancing health outcomes.
• The market's growth is fueled by the increasing adoption of these personalized and adaptive interventions across various sectors. According to recent studies, the market is experiencing a notable shift towards digital therapeutics, with a growing number of patients and healthcare providers recognizing their benefits. This trend is expected to continue driving market expansion during the forecast period.

What challenges does the Digital Therapeutics Industry face during its growth?

• The high development and regulatory costs pose a significant challenge to the growth of the industry. In order to succeed, companies must effectively manage these expenses and navigate complex regulatory frameworks. 

• The market faces substantial challenges due to the high costs involved in product development and regulatory compliance. These expenses include research and development, clinical trials, and regulatory filings to establish digital medicine as a viable alternative to traditional pharmaceuticals. The regulatory approval process, carried out by organizations like the FDA, can be lengthy and costly, posing a significant barrier to market entry for smaller businesses.
• This financial burden can hinder innovation and competitiveness, making it difficult for new players to become profitable and secure financing. Despite these challenges, the market continues to evolve, offering potential solutions to various healthcare needs. The market's ongoing development and the pursuit of more cost-effective methods will likely contribute to its growth and expansion.

Exclusive Customer Landscape

The digital therapeutics market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the digital therapeutics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Digital Therapeutics Industry

Competitive Landscape & Market Insights

Companies are implementing various strategies, such as strategic alliances, digital therapeutics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

2Morrow Inc. - Digital therapeutics, a subset of digital health, have gained significant traction due to their potential to deliver evidence-based interventions and improve patient outcomes. These technology-driven solutions offer personalized care, real-time monitoring, and data-driven insights, making them valuable additions to traditional healthcare services. By addressing various health conditions, digital therapeutics have the potential to revolutionize healthcare delivery and patient care.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• 2Morrow Inc.
• Akili Inc.
• Alphabet Inc.
• Better Therapeutics Inc.
• BigHealth 
• Brain+ ApS
• Canary Health
• Click Therapeutics Inc
• DarioHealth Corp.
• Digital Therapeutics Alliance Inc. 
• GAIA AG
• Jogo Health Inc.
• Limbix Health Inc.
• Medtronic PLC
• Noom Inc.
• Omada Health Inc.
• Pear Therapeutics Inc.
• ResMed Inc.
• Teladoc Health Inc.
• WellDoc Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Digital Therapeutics Market

• In January 2024, Pear Therapeutics, a leading digital therapeutics company, announced the FDA clearance of Somryst for the treatment of chronic insomnia. This mobile application-based therapeutic, the first of its kind, combines cognitive behavioral therapy for insomnia with biofeedback and sleep sensing technology (Pear Therapeutics Press Release, 2024).
• In March 2024, AbbVie and Novo Nordisk, two major pharmaceutical companies, formed a strategic collaboration to co-develop and commercialize digital therapeutics for diabetes management. This partnership aimed to leverage both companies' expertise in diabetes care and digital health technologies (AbbVie Press Release, 2024).
• In May 2024, Happify Health, a digital therapeutics company, secured a USD30 million Series C funding round led by new investors. This investment would be used to expand its offerings and reach more patients (Business Wire, 2024).
• In February 2025, the European Commission approved the marketing authorization for reSET-O, a digital therapeutic developed by Pear Therapeutics, for the treatment of opioid use disorder. This marked the first digital therapeutic to receive regulatory approval in the EU for this indication (European Medicines Agency, 2025).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Digital Therapeutics Market insights. See full methodology.

Request Free Sample

Research Analyst Overview

• In the dynamic and innovative landscape of digital therapeutics, wearable sensor data plays a pivotal role in driving advancements. These technologies collect vital health information, feeding artificial intelligence algorithms to enhance behavioral health programs. Patient adherence metrics derived from this data are crucial for the success of these interventions. Augmented reality therapy and mobile health apps are revolutionizing health behavior change by providing immersive experiences. Machine learning models analyze this data to personalize interventions, improving therapeutic efficacy. Cognitive behavioral therapy, traditionally delivered in clinical settings, is now being augmented by software validation processes and telehealth integration.
• Clinical trial outcomes demonstrate the effectiveness of digital therapeutics in chronic disease management. Virtual reality therapy and prescription digital therapeutics are increasingly being adopted, with evidence-based interventions showing promising results. Interoperability standards and data security protocols ensure seamless integration and protect patient privacy. Health outcome assessments, remote patient monitoring, and clinical validation studies are essential components of digital therapeutics. Personalized medicine apps, gamified health interventions, and patient reported outcomes further enrich the user experience. Mobile application development and user experience design are critical for ensuring patient engagement. Data analytics dashboards provide valuable insights into treatment efficacy, enabling continuous improvement.
• Digital biomarker detection offers new opportunities for early disease diagnosis and intervention. The market is witnessing a surge in innovation, with ongoing efforts to refine patient engagement platforms and improve data security protocols.

What are the Key Data Covered in this Digital Therapeutics Market Research and Growth Report?

• What is the expected growth of the Digital Therapeutics Market between 2024 and 2028?

  • USD 19.17 billion, at a CAGR of 32.59%

• What segmentation does the market report cover?

  • The report segmented by Product (Software and Devices), End-user (Business-to-Consumer and Business-to-Business), Geography (North America, Europe, Asia, and Rest of World (ROW)), and Application (Preventive Applications, Prediabetes, Obesity, Smoking Cessation, Treatment/Care Applications, Diabetes, Mental Health, Cardiovascular Diseases, Chronic Respiratory Diseases, Substance Abuse, Musculoskeletal Disorders, and Others)

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Increasing prevalence of chronic diseases, High development and regulatory costs

• Who are the major players in the Digital Therapeutics Market?

  • Key Companies 2Morrow Inc., Akili Inc., Alphabet Inc., Better Therapeutics Inc., BigHealth , Brain+ ApS, Canary Health, Click Therapeutics Inc, DarioHealth Corp., Digital Therapeutics Alliance Inc. , GAIA AG, Jogo Health Inc., Limbix Health Inc., Medtronic PLC, Noom Inc., Omada Health Inc., Pear Therapeutics Inc., ResMed Inc., Teladoc Health Inc., and WellDoc Inc.

Market Research Insights

• The market encompasses a range of solutions designed to improve clinical effectiveness in various health conditions. According to industry estimates, this sector is projected to reach USD12.5 billion by 2025, representing a significant growth from the USD2.2 billion market size in 2020. Two key components driving this expansion are the integration of data from mHealth technology and the implementation of regulatory pathways for digital health interventions. Clinical effectiveness measures in digital therapeutics span from health coaching programs and remote monitoring systems to data visualization tools and clinical decision support. For instance, therapeutic adherence rates have been shown to increase by up to 30% through the use of medication adherence support tools.
• In contrast, traditional paper-based methods yield adherence rates as low as 50%. These improvements contribute to better treatment effectiveness and population health management. Data integration strategies, such as real-world evidence and patient-reported outcomes, are essential for evaluating the impact of digital therapeutics platforms on patient health. Personalized treatment plans, risk stratification models, and patient activation measures are some of the key elements that enable health equity considerations and improve patient engagement in their care. The software development lifecycle for digital therapeutics involves rigorous testing and validation to ensure safety, efficacy, and usability.

We can help! Our analysts can customize this digital therapeutics market research report to meet your requirements.

Get in touch